Patents Assigned to Ed. Geistlich Soehne AG fuer Chemische Industrie
  • Publication number: 20030039695
    Abstract: A collagen matrix material is charged with a cell growth-promoting derived nucleic acid sequence. The nucleic acid sequence-charged collagen matrix material may be utilized in a method of promoting regeneration of surface cartilage of a joint. In the method, an area of injury is covered with the nucleic acid sequence-charged collagen matrix material, the collagen matrix material is fixed over the area to be treated, and the area is allowed to heal.
    Type: Application
    Filed: August 7, 2002
    Publication date: February 27, 2003
    Applicant: ED. GEISTLICH SOEHNE AG FUER CHEMISCHE INDUSTRIE
    Inventors: Peter Geistlich, Lothar Schloesser
  • Patent number: 6488912
    Abstract: A method of therapeutic treatment of an area of severe infection of soft tissue within or surrounding a tooth of a patient involves administering Taurolidine, Taurultam or mixtures thereof to the area of severe infection.
    Type: Grant
    Filed: July 1, 1999
    Date of Patent: December 3, 2002
    Assignee: Ed. Geistlich Soehne AG fuer Chemische Industrie
    Inventors: Rolf Wilhelm Pfirrmann, Peter Geistlich
  • Patent number: 6352558
    Abstract: A method of promoting regeneration of surface cartilage of a joint includes the steps of forming punctures in a subchondral plate of an area of the joint to be treated, covering the puncture and the area to be treated with a chondrocyte-free patch made of a sheet of collagen membrane material without adding chondrocytes to the area to be treated, fixing the patch over the area to be treated, and allowing the area to be treated to regenerate cartilage without adding chondrocytes to the area to be treated.
    Type: Grant
    Filed: December 29, 1999
    Date of Patent: March 5, 2002
    Assignee: Ed. Geistlich Soehne AG fuer Chemische Industrie
    Inventor: Myron Spector
  • Patent number: 6326029
    Abstract: A resorbable extracellular matrix for reconstruction of cartilage tissue, the matrix being substantially free from non-native collagen, and including a purified collagen II material formed form natural cartilage and having fibers of native collagen II which are physiologically acceptable for implant into a mammalian body.
    Type: Grant
    Filed: November 10, 1997
    Date of Patent: December 4, 2001
    Assignee: Ed Geistlich Soehne AG fuer Chemische Industrie
    Inventors: Peter Geistlich, Myron Spector, Zdenek Eckmayer
  • Patent number: 6258797
    Abstract: The use of taurolidine or taurultam in a method of combatting infection or sepsis in delivery systems is disclosed. In the method, taurolidine or taurultam solutions are used as a temporary seal or flush to prevent or reduce sepsis in delivery systems, such as port systems and/or catheters by which liquids are delivered into a patient.
    Type: Grant
    Filed: June 21, 1999
    Date of Patent: July 10, 2001
    Assignee: Ed. Geistlich Soehne AG fuer Chemische Industrie
    Inventor: Joachim Hermann Lehner